Effect of tumor necrosis factor inhibitor therapy on osteoclasts precursors in ankylosing spondylitis

Detalhes bibliográficos
Autor(a) principal: Perpétuo, Inês Pedro
Data de Publicação: 2015
Outros Autores: Raposeiro, Rita, Caetano-Lopes, Joana, Vieira De Sousa, Elsa Cristina, Campanilho-Marques, Raquel, Ponte, Cristina, Canhao, Helena, Ainola, Mari, Fonseca, João Eurico
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10451/53425
Resumo: Copyright: © 2015 Perpétuo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
id RCAP_a95036539559982ec97da8f6a300e4ea
oai_identifier_str oai:repositorio.ul.pt:10451/53425
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Effect of tumor necrosis factor inhibitor therapy on osteoclasts precursors in ankylosing spondylitisCopyright: © 2015 Perpétuo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are creditedIntroduction: Ankylosing Spondylitis (AS) is characterized by excessive local bone formation and concomitant systemic bone loss. Tumor necrosis factor (TNF) plays a central role in the inflammation of axial skeleton and enthesis of AS patients. Despite reduction of inflammation and systemic bone loss, AS patients treated with TNF inhibitors (TNFi) have ongoing local bone formation. The aim of this study was to assess the effect of TNFi in the differentiation and activity of osteoclasts (OC) in AS patients. Methods: 13 AS patients treated with TNFi were analyzed at baseline and after a minimum follow-up period of 6 months. 25 healthy donors were recruited as controls. Blood samples were collected to assess receptor activator of nuclear factor kappa-B ligand (RANKL) surface expression on circulating leukocytes and frequency and phenotype of monocyte subpopulations. Quantification of serum levels of bone turnover markers and cytokines, in vitro OC differentiation assay and qRT-PCR for OC specific genes were performed. Results: RANKL+ circulating lymphocytes (B and T cells) and IL-17A, IL-23 and TGF-β levels were decreased after TNFi treatment. We found no differences in the frequency of the different monocyte subpopulations, however, we found decreased expression of CCR2 and increased expression of CD62L after TNFi treatment. OC number was reduced in patients at baseline when compared to controls. OC specific gene expression was reduced in circulating OC precursors after TNFi treatment. However, when cultured in OC differentiating conditions, OC precursors from AS TNFi-treated patients showed increased activity as compared to baseline. Conclusion: In AS patients, TNFi treatment reduces systemic pro osteoclastogenic stimuli. However, OC precursors from AS patients exposed to TNFi therapy have increased in vitro activity in response to osteoclastogenic stimuli.This work was supported by Fundação para a Ciência e Tecnologia (http://www.fct.pt/index.phtml.en) PhD grant (SFRH/BD/70533/2010) and in part by a research grant from Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp (http://www.merck.com/index.html - Merck_P08574). The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck Sharp & Dohme Corp.PLOSRepositório da Universidade de LisboaPerpétuo, Inês PedroRaposeiro, RitaCaetano-Lopes, JoanaVieira De Sousa, Elsa CristinaCampanilho-Marques, RaquelPonte, CristinaCanhao, HelenaAinola, MariFonseca, João Eurico2022-06-21T15:07:26Z20152015-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/53425engPLoS One. 2015 Dec 16;10(12):e014465510.1371/journal.pone.01446551932-6203info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:59:11Zoai:repositorio.ul.pt:10451/53425Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:04:22.502841Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Effect of tumor necrosis factor inhibitor therapy on osteoclasts precursors in ankylosing spondylitis
title Effect of tumor necrosis factor inhibitor therapy on osteoclasts precursors in ankylosing spondylitis
spellingShingle Effect of tumor necrosis factor inhibitor therapy on osteoclasts precursors in ankylosing spondylitis
Perpétuo, Inês Pedro
title_short Effect of tumor necrosis factor inhibitor therapy on osteoclasts precursors in ankylosing spondylitis
title_full Effect of tumor necrosis factor inhibitor therapy on osteoclasts precursors in ankylosing spondylitis
title_fullStr Effect of tumor necrosis factor inhibitor therapy on osteoclasts precursors in ankylosing spondylitis
title_full_unstemmed Effect of tumor necrosis factor inhibitor therapy on osteoclasts precursors in ankylosing spondylitis
title_sort Effect of tumor necrosis factor inhibitor therapy on osteoclasts precursors in ankylosing spondylitis
author Perpétuo, Inês Pedro
author_facet Perpétuo, Inês Pedro
Raposeiro, Rita
Caetano-Lopes, Joana
Vieira De Sousa, Elsa Cristina
Campanilho-Marques, Raquel
Ponte, Cristina
Canhao, Helena
Ainola, Mari
Fonseca, João Eurico
author_role author
author2 Raposeiro, Rita
Caetano-Lopes, Joana
Vieira De Sousa, Elsa Cristina
Campanilho-Marques, Raquel
Ponte, Cristina
Canhao, Helena
Ainola, Mari
Fonseca, João Eurico
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório da Universidade de Lisboa
dc.contributor.author.fl_str_mv Perpétuo, Inês Pedro
Raposeiro, Rita
Caetano-Lopes, Joana
Vieira De Sousa, Elsa Cristina
Campanilho-Marques, Raquel
Ponte, Cristina
Canhao, Helena
Ainola, Mari
Fonseca, João Eurico
description Copyright: © 2015 Perpétuo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
publishDate 2015
dc.date.none.fl_str_mv 2015
2015-01-01T00:00:00Z
2022-06-21T15:07:26Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10451/53425
url http://hdl.handle.net/10451/53425
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv PLoS One. 2015 Dec 16;10(12):e0144655
10.1371/journal.pone.0144655
1932-6203
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv PLOS
publisher.none.fl_str_mv PLOS
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134594983788544